Position
SIMPLEX TRADING, LLC in Mineralys Therapeutics, Inc.
Back to the book · All holders of MLYS
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$44.2K$36.29 → $27.09
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 4.8K | $174.3K | — | — | — | 0.0% |
| Q1 2026 | 19.6K | $529.9K | $27.09 | −$44.2K | $399.8K | 0.0% |